CRISPR

$115.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.64 (-3.85%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRISPR and other stocks, options, and ETFs commission-free!

About CRSP

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA.

CEO

Samarth Kulkarni

Employees

410

Headquarters

Zug, Zug

Founded

2014

Market Cap

8.82B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.24M

High Today

$119.37

Low Today

$114.32

Open Price

$119.28

Volume

1.07M

52 Week High

$220.20

52 Week Low

$42.83

Analyst Ratings

55%

of 20 ratings

Buy

55%

Hold

35%

Sell

10%

CRSP Earnings

-$1.50

-$0.20

$1.10

$2.40

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected Apr 27, After Hours